Don't dismiss that feeling of déjà vu. Today's market action was absolutely similar to last Monday's vaccine-fueled rally. This time, however, it wasn't Pfizer (PFE) and BioNTech (BNTX), but Moderna (MRNA, +9.6%) releasing good news about its trial candidate.
Early data suggests Moderna's mRNA-1273 vaccine is 94.5% effective, which Dr. Anthony Fauci, the nation's top infectious-diseases official, called "truly outstanding."
Better still, Moderna's vaccine can be stored for 30 days between 36 to 46 degree Fahrenheit (about what you'd find in a refrigerator), and for six months at -4 degrees. That's much more forgiving for storage and transportation purposes than Pfizer's vaccine, which must be kept at -94 degrees.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"Last week’s Pfizer news was great, but today's Moderna vaccine news is even better," says Ryan Detrick, chief market strategist for LPL Financial. "Being able to store the vaccine in a standard fridge for up to a month makes transportation and usability so much easier. Yes, new cases and hospitalizations are soaring, but we are inching closer to ending this pandemic."
And just like last week, investors gobbled up airlines, cruise lines and other COVID-battered stocks whose fates are tethered to vaccine success. The Dow Jones Industrial Average jumped 1.6% to a new high of 29,950, lifted by big gains from industrial stocks such as Boeing (BA, +8.2%) and Honeywell (HON, +3.5%).
Other action in the stock market today:
- The S&P 500 also hit a new high, gaining 1.2% to 3,626.
- The small-cap Russell 2000 rewrote the record books, soaring 2.4% to 1,785.
- Once again, the tech-heavy Nasdaq Composite lagged the group, finishing up 0.8% to 11,924.
How to Play This Rotation
Wall Street's pros continue to have faith in a continued rotation out of 2020's early winners and into the market's more battered (but recovering) names.
"The path of least resistance for equities seems to be higher at the moment as favorable vaccine news, along with less uncertainty regarding the election, is proving to be a positive catalyst in the near term," says Brian Price, Head of Investment Management for Commonwealth Financial Network. "It's encouraging that we're seeing a rotation from growth and momentum-oriented stocks to value and cyclical names."
We've previously highlighted ways to invest in value now -- stock investors can target these seven picks, while those who prefer funds can explore these seven options. You can leverage this movement in other ways, too, such as sector investing -- among these 16 sector funds are products that provide exposure to industrials, financials and other recovery-sensitive plays.
Another area of the market to watch is the biotechnology space. Yes, this contains companies involved in developing COVID vaccines and treatments, but in general, many healthcare plays should also get a boost when the pandemic recedes and providers can resume regular treatments.
Read on as we look at 14 biotech and biopharmaceutical stocks that look attractive as 2020 winds down and 2021 nears. This list includes Big Pharma firms that are adding biotech exposure, biotech-industry leaders and smaller biotechnology firms that are trying to catch their big break.
Disclaimer
Kyle Woodley was long BA as of this writing.
-
Stock Market Today: Stocks Close Mixed Amid War Angst, Nvidia AnxietyMarkets went into risk-off mode amid rising geopolitical tensions and high anxiety ahead of bellwether Nvidia's earnings report.
-
What the Comcast Cable Spinoff Means for InvestorsComcast has announced plans to spin off select cable networks and digital assets into a separate publicly traded company. Here's what you need to know.
-
Stock Market Today: Stocks Retreat on Renewed Inflation, Interest Rate QuestionsStocks were lower and yields were higher on Tuesday, with markets reflecting the uncertain transition from campaign promises to real-world policies.
-
Honeywell Is the Best Dow Jones Stock After Elliott Discloses a StakeA breakup of Honeywell's businesses could result in major upside for the blue chip stock over the next two years, the activist investor says.
-
Why Is Warren Buffett Selling So Much Stock?Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have TodayGoogle parent Alphabet has been a market-beating machine for ages.
-
Stock Market Today: Stocks Pause but Nvidia Hits New All-Time HighsThe major equity indexes were mostly mixed on Monday, but Nvidia hit yet another new all-time high.
-
Stock Market Today: UnitedHealth Selloff Drags on DowWhile the main indexes ended in the red, Walgreens Boots Alliance had its best day since 2008.
-
Boeing Looks to Raise Up to $25 Billion as Cash Woes SwirlBoeing stock is higher Tuesday after the aerospace giant filed to raise as much as $25 billion and entered a credit agreement worth $10 billion.
-
Stock Market Today: Tech Leads Stocks to Broad-Based GainsRisk appetite came back with a vengeance as oil and bonds took a breather.
